![]() ![]() ![]() But to truly gain insight, we need to consider other information, too. I find it very interesting to look at who exactly owns a company. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. The general public- including retail investors - own 23% stake in the company, and hence can't easily be ignored. In this sort of situation, it can be more interesting to see if those insiders have been buying or selling. Being so large, we would not expect insiders to own a large proportion of the stock. Our data suggests that insiders own under 1% of Abbott Laboratories in their own names. However, on some occasions too much power is concentrated within this group. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Management ultimately answers to the board. The definition of an insider can differ slightly between different countries, but members of the board of directors always count. View our latest analysis for Abbott Laboratories Let's take a closer look to see what the different types of shareholders can tell us about Abbott Laboratories. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait. Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). With 76% stake, institutions possess the maximum shares in the company. Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stockĮvery investor in Abbott Laboratories ( NYSE:ABT) should be aware of the most powerful shareholder groups. Given the large stake in the stock by institutions, Abbott Laboratories' stock price might be vulnerable to their trading decisionsĤ7% of the business is held by the top 25 shareholders ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |